W E D N E S D A Y , O C T O B E R 3 R D , 2 0 1 2p R E l i m i N A R Y p R O G R A m
Conference Highlights Get ready for the Russian Market through key sessions not to be missed:
Develop a pro-active market entry strategy to grow your business in the Russian dynamic pharma environment!
Overview
In the past years, the global pharmaceutical industry has been experiencing a shift in its development: a geographic swing away from the major mature markets, to a set of new dynamics in “pharmerging” countries.
The Russian pharmaceutical market is one of these most dynamic and rapidly growing markets. Presently, its healthcare system is undergoing major changes bringing substantial challenges and opportunities for multinational pharmaceutical companies. Understanding the new legislation and the direction of the country’s pharmaceutical industry is therefore essential for the success in Russia.
OctOber 3rd, 2012Cité Internationale Universitaire of Paris, France
A 2012 Satellite Event
Analyze the market dynamics and development perspectives. Understand the potential value of the Russian Market
Get a clear appraisal of what the Healthcare reforms will look like
Fuel sustainable development by M&A and Strategic Alliances
Analyse the development potential for Generics & Biosimilars and build dynamic strategies to grow your business
Understand the current challenges to reach the GMP standards and requirements
Discover the new challenges for the distribution sector
Gain a practical approach to clinical trials in different nosologies
1st editiOn
Pre l iminar y Program
W E D N E S D A Y , O C T O B E R 3 R D , 2 0 1 2p R E l i m i N A R Y p R O G R A m
360° REGulATORY REviEW
OvERviEW
STRATEGiC AlliANCES
Anna HArringtOn-MOrOzOvA, Scientific & Regulatory Director, regem consulting Ltd (UK) elena gAnkinA, Scientific & Regulatory Director, bMS (RU)
benjamin MunbLit, Director of the Analysis and Consultancy Department, comcon-Pharma (RU)
barbara vAn WiSSen, Director coordination, Emerging countries, Servier (FR) christoph gLAetzer, Vice President, Market Access - Asia Pacific, Janssen (SG) iMS representative Name To be confirmed (FR)
nikita MinAev, Director of Business Development, geropharm (RU)
08:30 - 09:00 Registration
10:30 - 11:00 Networking break
01:00 - 02:30 lunch break
11:00 - 11:30 Overview of the Russian pharmaceutical market: characteristics, major trends and forecasts
09:00 - 10:30 Future value of emerging BRiCS markets
11:30 - 12:15 New regulatory environment: challenges and opportunities
12:15 - 01:00 Strategic alliances: a key factor for a competitive market
Focus on the Russian pharmaceutical market
Russian and global pharmaceutical market Strategy of development and investment opportunities Introduction to the “Pharma 2020” Program
Understand the potential value of emerging BRICS markets Learn how to build dynamic strategies that will grow your business
Gain insight from leading pharma experts on emerging markets
Licensing and IP protection Regulatory requirements for drug approval, registration and control
Trends in the pricing and reimbursement system Reformation of drugs procurement performed by the state Antitrust regulation
International partnering: a tool for efficient business strategies’ implementation
Joint Venturing: partnering with domestic manufacturers Knowledge transfer and investing into Human Resources Local partnering: prospects of biopharmaceutical clusters development
Strategic investment into Biotech
plENARYSESSiON
W E D N E S D A Y , O C T O B E R 3 R D , 2 0 1 2p R E l i m i N A R Y p R O G R A m
Russian Market Access Conference is organized in conjunction with:
For more information about Innovation Days, please visit the event website: www.lifescience-outlook.com
DiSTRiBuTiON
CliNiCAl TRiAlS
03:15 - 04:00 New challenges for distribution sector
04:00 - 04:45 Overview of essential information for clinical trials in Russia
New challenges for distribution
Conducting clinical trials in Russia in practice
Distribution development models Creating a mutually beneficial relationship with distributors Partnering with pharmacy chains to make the difference to your distribution strategy
Additional revenue sources and costs optimization
Overview of the clinical trials environment Clinical trials procedures Outsourcing opportunities
Speakers invitedTo be confirmed
eugene SeLivrA, CEO, global clinical trials, LLc (USA) vladimir krechikov, Director of Business development, cromos Pharma (RU)
04:45 - 06:00 Networking Reception cOnference LAnguAge:
engLiSH
KEY GROWTH DRivERS
02:30 - 03:15 Ensuring a sustainable development for your business: what are the next steps?
Learn what will ensure sector growth in the coming years? Securing a market share: Generics, Biosimilars, OTC – what will be the key playing field in pharma over the next 10-15 years?
Creating the right mix for a competitive product portfolio
nickolay deMidOv, CEO, Pharmexpert (RU)
OctOber 3rd, 2012Cité Internationale Universitaire of Paris, France
A 2012 Satellite Event
universal medica Group106, Bureaux de la Colline92213 Saint-Cloud+33 (0)1 41 12 27 77
Nina Doumbadze, Project [email protected]
Laura Halley, Business [email protected]
www.lifescience-outlook.com/russianmarketaccess
find Out MOre...
cOntActS